The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Abstract
Oncogenic activation of the proto-oncogene c- abl in human leukemias occurs as a result of the addition of exons from the gene bcr and truncation of the first abl exon. Analysis of tyrosine kinase activity and quantitative measurement of transformation potency in a single-step assay indicate that variation in bcr exon contribution results in a functional difference between p210 bcr-abl and p185 bcr-abl proteins. Thus, foreign upstream sequences are important in the deregulation of the kinase activity of the abl product, and the extent of deregulation correlates with the pathological effects of the bcr-abl proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
GROFFEN, J., STEPHENSON, J., HEISTERKAMP, N., DEKLEIN, A., BARTRAM, C., & GROSVELD, G. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,599
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R. (1982) · Nature · doi:10.1038/300765a0 · Cited by 1,378
The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene
Ben-Neriah, Y., Daley, G. Q., Mes-Masson, A.-M., Witte, O. N., & Baltimore, D. (1986) · Science · doi:10.1126/science.3460176 · Cited by 806
Self-citationHermans, A., Heisterkamp, N., von Lindern, M., van Baal, S., Meijer, D., van der Plas, D., Wiedemann, L. M., Groffen, J., Bootsma, D., & Grosveld, G. (1987) · Cell · doi:10.1016/0092-8674(87)90007-9 · Cited by 387
McLaughlin, J., Chianese, E., & Witte, O. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6558 · Cited by 367
Self-citationUnique Forms of the abl Tyrosine Kinase Distinguish Ph 1 -Positive CML from Ph 1 -Positive ALL
Clark, S. S., McLaughlin, J., Crist, W. M., Champlin, R., & Witte, O. N. (1987) · Science · doi:10.1126/science.3541203 · Cited by 320
Self-citationN-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.
Jackson, P., & Baltimore, D. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03397.x · Cited by 278
Konopka, J. B., & Witte, O. N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.11.3116 · Cited by 250
Self-citationExpression of a Distinctive BCR-ABL Oncogene in Ph 1 -Positive Acute Lymphocytic Leukemia (ALL)
Clark, S. S., McLaughlin, J., Timmons, M., Pendergast, A. M., Ben-Neriah, Y., Dow, L. W., Crist, W., Rovera, G., Smith, S. D., & Witte, O. N. (1988) · Science · doi:10.1126/science.3422516 · Cited by 235
Self-citationFranz, W. M., Berger, P., & Wang, J. Y. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03358.x · Cited by 202
The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.
Lugo, T. G., & Witte, O. N. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1263 · Cited by 172
Self-citationHeterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic leukemia.
Erikson, J., Griffin, C. A., ar-Rushdi, A., Valtieri, M., Hoxie, J. A., Finan, J. B., Emanuel, B. S., Rovera, G., Nowell̀, P. C., & Croce, C. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1807 · Cited by 151
McLaughlin, J., Chianese, E., & Witte, O. N. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.5.1866 · Cited by 144
Self-citationHamaguchi, M., Grandori, C., & Hanafusa, H. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3035 · Cited by 122
Khazaie, K., Dull, T. J., Graf, T., Schlessinger, J., Ullrich, A., Beug, H., & Vennström, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03171.x · Cited by 121
Konopka, J. B., Davis, R. L., Watanabe, S. M., Ponticelli, A. S., Schiff-Maker, L., Rosenberg, N. E., & Witte, O. N. (1984) · Journal of Virology · doi:10.1128/jvi.51.1.223-232.1984 · Cited by 113
Self-citationChen, S., Flandrin, G., Daniel, M., et al. (1988) · PubMed · Cited by 65
Secker‐Walker, L. M., Cooke, H. M., Browett, P., Ca, S., Norton, J., Coustan‐Smith, E., & Hoffbrand, A. V. (1988) · Blood · doi:10.1182/blood.v72.2.784.784 · Cited by 62
Saglio, G. N., Guerrasio, A., Tassinari, A., Ponzetto, C., Zaccaria, A., Pp, T., Celso, B., Cambrin, G. R., Serra, A., & Pegoraro, L. (1988) · Blood · doi:10.1182/blood.v72.4.1203.1203 · Cited by 48
Muller, A. J., & Witte, O. N. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.5234 · Cited by 29
Self-citation
Cited by
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
The molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Metadata
- Authors
- Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N.
- Venue
- Science
- Published
- 1990-03-02
- Volume
- 247
- Issue
- 4946
- Pages
- 1079-1082
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2040396943
- Cited by
- 1,281
- References
- 21
- FWCI
- 16.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.